{
  "market": {
    "labels": ["2024", "2025", "2026", "2027", "2028", "2029", "2030"],
    "data": [140.4, 155, 171.1, 189, 208.7, 230.4, 254.6],
    "title": "CNS Market Size ($B)",
    "color": "#667eea"
  },
  "capital": {
    "labels": ["Anchors", "Bolt-Ons", "Reserves"],
    "data": [45, 35, 20],
    "colors": ["#667eea", "#764ba2", "#a855f7"]
  },
  "noeticOs": {
    "labels": ["FP&A", "Reg/QA", "Market Access", "Data/AI", "GTM", "People Ops"],
    "data": [20, 15, 10, 25, 30, 20],
    "max": 100,
    "color": "#667eea"
  },
  "platformKpis": {
    "labels": ["Revenue Growth", "EBITDA Margin", "Cross-Sell Rate", "Integration Speed"],
    "current": [15, 18, 12, 70],
    "target": [25, 25, 25, 90],
    "colors": {
      "current": "#e5e7eb",
      "target": "#667eea"
    }
  },
  "valueCreation": {
    "labels": ["Year 0", "Year 1", "Year 2", "Year 3", "Year 4"],
    "revenue": [0, 40, 80, 150, 200],
    "ebitdaMargin": [0, 15, 20, 25, 30],
    "colors": {
      "revenue": "#667eea",
      "ebitdaMargin": "#764ba2"
    }
  },
  "returnScenarios": {
    "labels": ["Base Case", "Upside Case", "Stress Case"],
    "data": [15, 25, 8],
    "colors": ["#10b981", "#667eea", "#ef4444"]
  },
  "phases": [
    {
      "id": "p0",
      "title": "Phase 0: Foundation",
      "duration": "Months 0-6",
      "metrics": {
        "operatingPartners": "0/3",
        "targetPipeline": "0/100+",
        "noeticOsDevelopment": "Planning",
        "firstLOIs": "Target: 20+"
      }
    },
    {
      "id": "p1", 
      "title": "Phase 1: Anchor",
      "duration": "Months 6-18",
      "metrics": {
        "revenueRange": "$35-75M",
        "ebitdaMargin": "20%+",
        "focusAreas": "Neurodiagnostics",
        "businessModel": "SaaS + Device"
      }
    },
    {
      "id": "p2",
      "title": "Phase 2: Bolt-Ons", 
      "duration": "Months 12-30",
      "metrics": {
        "targetCount": "3-6 acquisitions",
        "sizeRange": "$5-25M revenue",
        "integrationTimeline": "<18 months",
        "synergyTarget": "70% of underwrite"
      }
    },
    {
      "id": "p3",
      "title": "Phase 3: Scale",
      "duration": "Months 30-48", 
      "metrics": {
        "combinedRevenue": "$150M+ target",
        "ebitdaMargin": "25%+ target",
        "fcfYield": "15%+ target",
        "revenueInvestedCapital": "1.2x+ target"
      }
    },
    {
      "id": "p4",
      "title": "Phase 4: Exit",
      "duration": "Months 48-72",
      "metrics": {
        "revenueRunRate": "$200M+ target",
        "ebitdaMargin": "30%+ target", 
        "growthRate": "20%+ sustainable",
        "marketPosition": "Top 3 in niche"
      }
    }
  ],
  "capitalPlan": {
    "targetFundSize": "$500M - $1.5B",
    "anchorAllocation": "40-50%",
    "boltOnAllocation": "30-40%", 
    "reserves": "20-30%"
  },
  "risks": [
    {"level": "high", "name": "Integration Execution"},
    {"level": "medium", "name": "Regulatory/Payer"},
    {"level": "high", "name": "Talent Retention"},
    {"level": "medium", "name": "Market Timing"},
    {"level": "medium", "name": "Competition"},
    {"level": "low", "name": "Technology Risk"}
  ]
}